Mirada Medical, an Oxford, United Kingdom, and Denver, CO-based provider of a software product for doctors to use medical images to diagnose and treat cancer, received an additional funding.
UK-based Albion Ventures is investing a further £0.85m in addition to new equity which was acquired by the employees and founders of the company.
The company intends to use the funds to expand its product distribution worldwide and accelerate product development through the addition of new scientific and engineering positions at their Oxford, UK headquarters.
Founded in 2001 and led by Hugh Bettesworth, CEO, Mirada Medical provides software solutions that are routinely used in radiology, molecular imaging, radiation oncology and in multidisciplinary meetings throughout hospitals, imaging centres and cancer centres worldwide. Products are available directly from the company, and also through a network of healthcare companies such as Varian, GE, McKesson, Siemens, Vital Images and select others. by medical imaging researchers at Oxford University.
The software is used by cancer centres and hospitals around the globe, including: Oxford Cancer Centre, Clatterbridge Cancer Centre, Gray Institute for Radiation Oncology and Biology, Rikshospitalet, Copenhagen, MD Andersen Cancer Centre, Johns Hopkins Medical Centre, Memorial Sloan Kettering Hospital and UCLA.
FinSMEs
06/04/2014